                </a></li></ul></div><p><strong>Figure 3.  <span>The combination therapy of Etanercept and HSP60 180-188 led to an antigen specific increase of IL-10 and IL-4 production and up regulation of CTLA-4 expression in CD4+ T cells in draining Mandibular Lymphnodes (MLN).</span></strong></p><a id="article1.body1.sec3.sec3.fig1.caption1.p1" name="article1.body1.sec3.sec3.fig1.caption1.p1"></a><p>MLN were harvested on day 23 after the induction of arthritis.</p>
<a id="article1.body1.sec3.sec3.fig1.caption1.p2" name="article1.body1.sec3.sec3.fig1.caption1.p2"></a><p>Cells were cultured for 72 hours with medium or antigen.</p>
<a id="article1.body1.sec3.sec3.fig1.caption1.p3" name="article1.body1.sec3.sec3.fig1.caption1.p3"></a><p>Intracellular production of IL-4, IL-10, and expression of CTLA-4 were measured by FACS.</p>
<a id="article1.body1.sec3.sec3.fig1.caption1.p4" name="article1.body1.sec3.sec3.fig1.caption1.p4"></a><p>Depicted are Mean Fluorescence Indexes (MFI) of MLN cells cultured with mycobacterial HSP60 peptide 180-188, of cells gated on CD4.</p>
<a id="article1.body1.sec3.sec3.fig1.caption1.p5" name="article1.body1.sec3.sec3.fig1.caption1.p5"></a><p>Results are representative of one experiment.</p>
